dihexa human clinical trials 2026 International Day 2026: inside First-in-Human trials Dihexa for Memory: What the

Similarly, both groups traveled longer distance in the platform quadrant than the controls did ( P = 0.0467 for the combination group and P = 0.0191 for the standard drug group

Microglia NLRP3 Inflammasomes activation involving diabetic Neuroinflammation in diabetic mice and BV2 cells

Both in vitro and in vivo research involving rat tendons has shown that BPC-157 promotes collateralization and boosts fibroblast density in the setting of tendon, ligament, and bone injury

Increasing evidence suggests that soluble A oligomers, rather than insoluble plaques, are major contributors to synaptic dysfunction and cognitive decline in AD, although their precise pathogenic role remains under active investigation and debate (Selkoe, 2008